Veronika Navrkalova
Brno, JM, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Targeted gene expression profiling as a tool for diagnostic cell-of-origin determination and prognostic stratification in diffuse large B-cell lymphoma.
Journal: Ceskoslovenska patologie
Published: April 17, 2026
Assessment of long-read strategies for the enrichment of clinically relevant breakpoints in lymphomas: towards a diagnostic implementation.
Journal: Annals of hematology
Published: September 29, 2025
Reliable detection of CNS lymphoma-derived circulating tumor DNA in cerebrospinal fluid using multi-biomarker NGS profiling: insights from a real-world study.
Journal: Biomarker research
Published: February 05, 2025
Advanced NGS analysis of cell-free tumor DNA supports clonal relation to primary high-grade B-cell lymphoma lesion and CNS relapse despite MRI negativity.
Journal: Diagnostic pathology
Published: May 27, 2024
Circulating free DNA and its potential in the diagnostics and therapy of malignant lymphoma.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: January 09, 2024
Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single-cell RNA sequencing.
Journal: Molecular oncology
Published: December 14, 2023
Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients.
Journal: British journal of haematology
Published: July 25, 2023
Very rare near-haploid acute lymphoblastic leukemia resistant to immunotherapy and CAR-T therapy in 19-year-old male patient.
Journal: Clinical case reports
Published: October 28, 2021
Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on BCR-ABL1-like subtype.
Journal: Acta oncologica (Stockholm, Sweden)
Published: March 22, 2021
The Effect of SF3B1 Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in Cancer.
Journal: Frontiers in oncology
Published: September 23, 2020
Last Updated: 09/26/2026